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ABSTRACT
In recent years, the zebrafish has emerged as an increasingly
prominent model in biomedical research. To showcase the
translational impact of the model across multiple disease areas,
Disease Models & Mechanisms has compiled a Special Issue that
includes thought-provoking reviews, original research reporting new
and important insights into disease mechanisms, and novel
resources that expand the zebrafish toolkit. This Editorial provides a
summary of the issue’s contents, highlighting the diversity of
zebrafish disease models and their clinical applications. 
Special Issue: Spotlight on Zebrafish
One aim of a Disease Models & Mechanisms (DMM) ‘Special
Issue’ is to highlight how emerging disease models can lead to
exceptional growth in particular areas of translational research. This
is especially true for this issue, Spotlight on Zebrafish: Translational
Impact. The zebrafish has traditionally been used to study
developmental biology. Its optical transparency for the first few
weeks, high fecundity and ex vivo fertilization have meant that the
fundamental processes and mechanisms of vertebrate embryo
development from a single cell through to a swimming fish can be
studied in exquisite detail. Over the past decade these same features
have enabled the zebrafish to become a preeminent disease model
and tool for studying disease mechanisms. Importantly, discoveries
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in zebrafish disease models are leading to new perspectives on
human disease and new drugs that are entering the clinic in diverse
areas from cancer to tuberculosis. 
We are delighted to present an issue packed with reviews,
research and resource articles from researchers at the cutting-edge
of their respective disease area of interest. The issue also includes a
compelling interview with Len Zon, pioneer in the zebrafish disease
models community, and a unique poster representation of the
translational applications of zebrafish research. Here, we summarize
the contents of the issue, and give our views on what makes each
article special.  
Front section of the issue: Reviews and more 
Kicking off the front section of the issue, Jennifer Phillips and
Monte Westerfield provide an overview of the use of zebrafish in
translational research in an ‘At a Glance’ poster article. The poster,
which can be downloaded from the DMM website, highlights the
unique strengths of the model and the advances in technologies that
have expanded the zebrafish toolbox. The authors also illustrate
recent examples of successful clinical translation of zebrafish
studies. One of the examples, the groundbreaking discovery by the
Zon lab of a new treatment strategy for melanoma, is described by
Len Zon in his own words in an exclusive ‘Model for Life’
interview. As well as telling the stories behind some of the key
milestones in his career, Len provides his perspectives on emerging
challenges and opportunities in zebrafish research. 
In the first of two cancer-focused Reviews, Jason Berman and
colleagues provide a compelling argument to support the use of
zebrafish xenotransplantation for preclinical cancer drug screening
and testing. Next, Jessica Blackburn and David Langenau explain
how intratumoral heterogeneity can present an obstacle to cancer
therapy, and underscore the utility of zebrafish models for exploring
the molecular basis of clonal evolution in tumorigenesis. 
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Aarti Asnani and Randal Peterson then review the impressive
array of zebrafish studies that have provided important mechanistic
insights into cardiovascular disorders and paved the way for
development of novel therapies. Wolfram Goessling and Trista
North also touch upon cardiac regeneration as part of a broader
review of recent zebrafish-driven advances in regenerative medicine.
Focusing particularly on the hematovascular and gastrointestinal
systems, the authors discuss how the regenerative capacity of the
organism can be exploited to devise therapeutic strategies to
promote organ-specific repair in response to injury and disease. 
An important area that has advanced significantly as a direct
result of using the zebrafish is tuberculosis research, and these
discoveries and their therapeutic implications are reviewed by Mark
Cronan and David Tobin. A Review by Annemarie Meijer and
colleagues further illuminates the power of the model for
understanding and treating infectious diseases. Their article
describes the insights into macrophage-pathogen interactions that
have been gained using zebrafish infection models, and illustrates
how these insights have unveiled promising therapeutic candidates
to combat diverse bacterial and fungal pathogens. 
Finally, Pierre Drapeau’s group review zebrafish models of
motor neuron disorders, with a particular focus on amyotrophic
lateral sclerosis (ALS). They highlight how these models have
enhanced our understanding of the underlying disease pathology and
are posed to advance drug discovery in the near future.   
New research, models and tools
In the research section of the issue, a striking example of how the
zebrafish can enable new insight into disease processes is presented
in an elegant study by Alexander Apschner, Stefan Schulte-
Merker and colleagues. Through phenotypic analysis of a genetic
mutant in ectonucleoside pyrophosphate/phosphor-diesterase
(enpp1), they discover ectopic soft-tissue calcifications, as observed
in humans with ENPP1 mutations. Interestingly, there is premature
development of osteoclast-like cells at the ectopic mineralization
sites, suggesting that osteoclasts might be promoting regression at
mineralization sites. This is a new concept for ectopic mineralization
diseases, such as generalized arterial calcification of infancy and
pseudoxanthoma elasticum, and has implications for bisphosphonate
treatments that both inhibit progression of calcifications but also
have known inhibitory effects against osteoclasts. 
The high genomic conservation between zebrafish and humans,
including the presence of orthologs for over 70% of human genes,
enables discoveries in zebrafish to be directly tested for relevance in
human disease. Ana Vacaru, Kirsten Sadler and colleagues analyze
zebrafish liver steatosis, protein markers and target gene expression
to provide a new perspective on the unfolded protein response (UPR)
and its role in fatty liver disease (FLD). They discover that, in
response to endoplastic reticulum (ER) stress, zebrafish embryos have
three distinguishable gene expression responses, and only one of these
responses leads to FLD (‘stressed UPR’). Importantly, markers of this
stressed UPR significantly correlated with steatosis in zebrafish, and
also in humans with FLD. Surprisingly, a different UPR subclass leads
to an adaptive and protective response, suggesting that promoting an
adaptive UPR response might actually be beneficial in the context of
diseases caused by high UPR induction.
Gene expression analysis is also an important feature in a paper
that aims to dissect the molecular mechanisms underlying a
pancreatic phenotype in a urod mutant, a model of human
hepatoerythropoietic porphyria. By analyzing the gene expression
changes in urod mutants, Shuqing Zhang, Han Wang and
colleagues discover a class of peptidase precursor genes that are
specifically downregulated in the mutant zebrafish. The authors go
on to demonstrate a heme-dependent mechanism that regulates
expression of exocrine zymogens by enabling a switch from a
repressive Bach1b-MafK heterodimer to an activating Nrf2a-MafK
heterodimer. This heme-dependent mechanism and decreased
pancreatic zymogen production could explain some of the clinical
features of porphyria, which include acute episodic abdominal pain.  
Forward genetic screens have been a long-standing feature and
strength of the zebrafish system. Tamara Stawicki, David Raible
and colleagues use forward genetics to identify new genes involved
in resistance to hearing loss, a disorder that affects over 35% of
people over 65. They identify a mutation in the transcription factor
gcm2 that is resistant to neomycin-induced hair cell death, and is
important for whole body pH regulation. Defects in gcm2 lead to
impaired mechanotransduction ability, subsequent reduced drug
uptake and audiovestibular behavioral defects. This is the second
example of a genetic mutation that links pH regulation to hair cell
sensitivity to ototoxic drugs, and points to pH regulation as an
important role in this process.
Zebrafish models can fill the gap for diseases where there are few
models or treatments. Alexa Burger, Daniel Haber and colleagues
demonstrate this by providing a new model of chordoma, a rare type
of bone cancer that is thought to arise from the remnants of
embryonic notochord cells. Until now, there has been no animal
model of chordoma, few cell lines and limited treatment options.
Burger et al. show that expression of oncogenic HRASV12 in the
notochord rapidly induces the development of tumors that resemble
human chordoma. Treatment with the mTOR inhibitor rapamycin,
which has shown promise for treating human chordoma, delays
tumor onset and improves zebrafish survival. This model opens new
doors for high-throughput chemical screening for therapeutic agents
to treat this cancer. 
The development of new and improved disease models depends
on good tools and methods, and two studies presented here should
greatly enhance the zebrafish toolkit. Rosa Miyares, Vitor de
Rezende and Steven Farber present zebrafish yolk lipid
processing as a new tool to study lipid metabolism and
dyslipidemias, a major risk factor for heart disease and cause of
mortality. Using fatty acids labeled with fluorescent or radioactive
tracers, the metabolism and fate of the lipid is followed in live
zebrafish. The methods described will be important for studying
the fundamental processes of lipid metabolism, and also for
studying lipid metabolism in the context of genetic models of
disease and developing new therapeutic regulators. Wouter Koole
and Marcel Tijsterman use a genetic approach that relies on
microsatellite instability to develop a new tool for mosaic analysis.
Optimized for the GAL4-UAS system, the authors show that
placing genes behind unstable microsatellite-dependent sequences
can lead to stochastic activation in vivo. They demonstrate the
success of their approach by placing oncogenic H-RASG12V under
the control of microsatellite sequences and demonstrate tumor
development from a single cell. This approach should enable the
etiology and pathology of cancer to be studied within the context
of otherwise wild-type animals. 
One of the principal strengths of the zebrafish is its amenability
to intravital imaging of cellular processes in unprecedented detail.
Tjakko Van Ham, Ben Giepmans and colleagues use imaging to
study the resolution of neuroinflammation in vivo. Using a model of
neurodegeneration that genetically targets brain cells for cell death,
they follow the kinetics and nature of the immune response
following injury and find that peripheral macrophages and resident
microglia clear the dying cells. The timing of these cells is different
















and, remarkably, clearance involves phagocyte apoptosis and
engulfment by microglia. These new insights into the cellular
mechanisms involved in clearing degenerated cells could be
important for diseases such as Alzheimer’s disease. Exquisite
imaging is also a feature of the research by Mai Nguyen-Chi,
Georges Lutfalla and colleagues, who were able to model chronic
inflammation using a transient Escherichia coli infection model in
the notochord. Bone and cartilage inflammation can lead to
progressive bone and joint destruction, but models of chronic
inflammation in these tissues are lacking. Using the notochord as a
site for inflammation, the authors transiently infect the notochord
with an E. coli pathogen that is rapidly cleared but nonetheless
triggers a persistent immune response. The persistent immune
response is characterized by neutrophils undergoing degranulation
next to the notochord in the absence of a pathogen in vivo, leading
to tissue damage and eventually dysmorphic vertebrae development.
Thus, both these studies demonstrate the power of high-resolution
live imaging in zebrafish models to visualize novel cellular events
that underlie pathology. 
Imaging is not just limited to the embryonic forms. Using larval
and adult zebrafish, Marco Schiavone, Francesco Argenton and
colleagues engineer reporter lines for signaling pathways into a
model of pancreatic adenocarcinoma and medulloblastoma. This
enables the dynamics of cancer signaling pathways to be traced in
vivo, and reveals tissue-specific regulation of cell-signaling
pathways between cancer types. These lines prove valuable for
visualizing tumor development in situ, and could become
particularly relevant in the context of visualizing cancer drug
response in live adult fish. 
Ultimately, understanding disease mechanism in zebrafish disease
models can lead to new treatments. This is exemplified in a study
by Nadia Danilova, Shuo Lin and colleagues, who find activation
of DNA damage checkpoints, and upregulation of genes involved in
nucleotide catabolism and biosynthesis, in two genetic models of
ribosomal protein (RP) deficiency. Human fetal liver cells deficient
for RPS19 also show signs of replicative stress and the DNA
damage response, suggesting that the cellular response to RP
deficiency is conserved between zebrafish and humans. Because
nucleosides have been used to treat other conditions of replicative
stress in cells, the authors treat their RP-deficient zebrafish models
with exogenous nucleosides and discover that this leads to improved
survival, increased blood count and decreased morphological
defects. The authors suggest that exogenous nucleoside supplements
might be of novel therapeutic benefit for humans with RP
deficiency, as observed in Diamond Blackfan anemia patients. 
What is particularly impressive about our collection – and the
field at large – is the diversity of disease models and their relevance
to human disease. The response to our ‘call for papers’ and
invitations to write reviews has been outstanding, and we hope you
enjoy reading and sharing the issue as much as we have enjoyed
bringing it to you. Please be sure to keep an eye on the DMM
zebrafish collection page at http://dmm.biologists.org/site/
collections/zebrafish.xhtml to read further zebrafish articles
reporting new and exciting insights into disease in the coming
months. 
This article is part of a Special Issue, Spotlight on Zebrafish: Translational Impact.
See all the articles in the issue at http://dmm.biologists.org/content/7/7.toc.
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